We investigated energy metabolism enhancement by pepper by examining suppression of body fat accumulation in mice due to piperine (PIP) and black pepper (BP) intake. To induce adiposity, mice were fed a highfat, high-sucrose (HFS) diet as a control diet for 4 weeks. Visceral fat weights decreased significantly in the mice fed diets of 0.03% and of 0.05% PIP. Body weight in the 0.05% PIP group also decreased significantly. In the mice fed a diet of 1.0% BP, body weight and visceral fat weights decreased significantly. For all parameters tested, the 1.0% BP group tended to show values slightly lower than those of the 0.03% PIP group. Expression of thermogenic protein uncoupling protein 1 tended to increase in the mice on the 1.0% BP diet. These results indicate that BP suppresses the effect of body fat accumulation mainly through the action of PIP. and prokinetic effects.
and prokinetic effects. 3) Piperine (PIP) is a pungent component of pepper. It has been reported that PIP acts on the capsaicin (CAP) receptor, also known as the transient receptor potential cation channel, subfamily V, member 1 (TRPV1). [4] [5] [6] TRPV1 is activated by CAP, a pungent component of hot pepper. It is known that TRPV1 activation enhances energy metabolism. 7) Thus it is possible that like CAP, PIP can enhance energy metabolism via TRPV1, although there is no current supporting evidence. On the other hand, various PIP analogs that act on TRPV1 have been identified in BP, 6) indicating that TRPV1 agonists other than PIP can enhance energy metabolism. In this study, we investigated the energy metabolism enhancement of pepper by examining its suppressive effect on body fat accumulation in mice given PIP. The suppressive effect on body fat accumulation by BP intake was also investigated to confirm the action of pepper components other than PIP.
Materials and Methods
Chemicals. Piperine (PIP, purity !98:0%) was from Sigma-Aldrich (St. Louis, MO, USA). Black pepper (BP) was from GABAN (Tokyo, Japan). Anti-uncoupling protein 1 (UCP1) rabbit polyclonal antibody was from EMD Chemical (Darmstadt, Germany). ECL anti-rabbit IgG horseradish peroxidase-linked whole antibody and an ECL Western blotting analysis system were from GE Healthcare UK (Buckinghamshire, UK). All other chemicals were of guaranteed reagent grade.
Measurement of piperine in black pepper by HPLC analysis.
Piperine was extracted from BP by stirring for 2 d with 80% acetone at room temperature under shade. The extract was evaporated to dryness after filtration. The BP extract solution (1.0 mg/ml) was prepared by adding methanol. To create a standard curve, 0.1-, 1.0-, and 2.0-mM PIP solutions were prepared. The PIP content in the BP was quantified by high-performance liquid chromatography (HPLC) using a J'sphere ODS-H80 column (4:6 Â 150 mm; YMC, Kyoto, Japan) eluted with a linear gradient from 60 to 100% methanol for 12 min, followed by 100% methanol for 8 min. The flow rate was adjusted to 1 ml/min, and the UV detector was set at 260 nm.
Animals and experimental procedures. Five-week-old C57BL/6J male mice (Japan SLC, Shizuoka, Japan) were used. They were housed individually in a room under controlled temperature (23 AE 1 C), humidity (55 AE 5%), and light cycle (light from 0700 to 1900). All animal experiments were approved by the Animal Care and Use Committee of the University of Shizuoka.
The compositions of the experimental diets are shown in Table 1 . A high-fat, high-sucrose (HFS) diet based on AIN-93G, 8) used to induce obesity, was prepared as a control diet. The HFS diet contained, on an energy basis, 31.9% carbohydrate including sucrose, 25.0% protein, and 48.0% fat. The increase in lipid and sucrose was eliminated with -corn starch.
When suppression of body fat accumulation induced by PIP was investigated, two pairs of experimental group were designed. One was a PIP-addition group at the 0.03 and 0.05% levels. The other was a 0.03% PIP, 1.0% BP-addition group. The BP used contained about 3% PIP by HPLC analysis and the PIP contents at the two levels (0.03% PIP and 1.0% BP) were the same. The energy levels of the HFS, HFS þ 0:03% PIP, þ0:05% PIP, and HFS þ 1:0% BP groups are 20.54, 20.53, 20.52, and 20.33 kJ/g, respectively.
After a 1-week adaptation period with a powdered standard laboratory diet (MF; Oriental Yeast, Tokyo, Japan), mice were * Y.O. and M.N. contributed equally to this study.
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After the feeding experiment, the mice were starved for 8 h and dissected under ether anesthesia. Blood was withdrawn from the inferior vena cava, and tissues, heart, spleen, liver, kidney, pancreas, interscapular brown adipose tissue (IBAT), mesenteric white adipose tissue (WAT), perinephric WAT, and epididymal WAT were extirpated. IBAT was frozen with liquid nitrogen and kept at À80 C until uncoupling protein 1 (UCP1) content assay. Collected blood was stored overnight at 4 C, and the serum was separated by centrifugation. Serum glucose, triglyceride, total cholesterol, and non-esterified fatty acid (NEFA) were measured using 96-well microplate and commercial kits (Wako Pure Chemical Industries, Osaka, Japan) at one-twentieth of the scale described in the supplier's manual. Absorbance was measured using a microplate reader (SpectraMax 190; Molecular Devices, Sunnyvale, CA, USA).
Measurement of UCP1 content in IBAT. The mitochondrial fraction was prepared following Cannon and Lindberg.
9) The IBAT was minced with scissors and homogenized with 300 ml of sucrose buffer (0.3 M sucrose, 10 mM Tris, 2.2 mM ethylenediaminetetraacetic acid, pH 7.2). The supernatant containing the microsome fraction was discarded. The remaining pellet was rehomogenized with 50 ml of sucrose buffer and transferred to a microtest tube. Sucrose buffer (450 ml) was added, and the tube was shaken well. The resulting suspension was centrifuged at 700 Â g for 10 min at 4 C. The supernatant containing the mitochondrial fraction was also transferred to a microtest tube and centrifuged at 8;500 Â g for 10 min at 4 C. The supernatant was discarded, and 30 ml of 0.25 M sucrose was added and this was homogenized. After 40 Â dilution with 0.25 M sucrose, the mitochondrial protein content in the resulting solution was measured using a Bradford UltraÔ reagent kit (Expendeon, Cambridge, UK).
The UCP1 content of the mitochondrial fraction in the IBAT was measured by Western blotting. A portion (2.5 mg of protein) of the mitochondrial fraction was analyzed by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (12%), and the protein was transferred to a PVDF membrane. The PVDF membrane was soaked with a 5% skim milk aqueous solution for 1 h at room temperature and washed with Tween-PBS solution. The solution was then soaked with a primary antibody (anti-UCP1 rabbit polyclonal antibody) in Tween-PBS (1:2,000) for 1 h at room temperature, followed by washing with Tween-PBS 3 times for 10 min each time, and treatment with a secondary antibody (ECL anti-IgG antibody) in Tween-PBS (1:20,000) for 1 h. After washing 3 times with Tween-PBS, ECL (GE Healthcare Bio-Sciences, Piscataway, NJ, USA) was added and this was reacted for 1 min at room temperature. The stained protein was detected using a LAS 3000 chemical luminescence detector (Fujifilm, Tokyo, Japan) and analyzed with MultiGauge software ver. 3.0 (Fujifilm). The protein content of the UCP1 was normalized to that of the HFS group.
Statistical analysis. All data are presented as mean AE standard error of mean (SEM). Statistical analyses were carried out using the Prism 4a software (GraphPad Software Inc., San Diego, CA, USA). Differences between the two groups were evaluated by an unpaired t test. Differences among more than three groups were analyzed by one-way analysis of variance (ANOVA) and Tukey's multiple comparison test. Differences were considered significant at p < 0:05.
Results

Suppression of body fat accumulation by PIP intake
First we investigated the suppression of body fat accumulation due to PIP intake. Among the CONT and PIP diet groups, total food intake and total energy intake over 4 weeks showed similar values ( Table 2 ). There was no significant difference in body weight between the 0.03% CONT and the 0.03% PIP group (Fig. 1A) . Compared with the 0.05% HFS group, body weight gain in the 0.05% PIP group tended to be suppressed (Fig. 1B) . The final body weight in the 0.05% PIP group was significantly lower than that in the 0.05% CONT group (Fig. 1B) . Thus, although there was no difference in total energy intake, body weight was decreased by 0.05% PIP addition. Neither the organ weights of the heart, spleen, liver, kidney, pancreas, and IBAT (data not shown) nor the values of the serum component were significantly different with PIP intake (Table 3 ). The weights of visceral adipose tissues are shown in Fig. 2 . The mesenteric, perinephric, and epididymal WAT weights in the PIP intake groups decreased as compared with the CONT groups. The mesenteric WAT weights in both the 0.03% and the 0.05% PIP group were significantly lower than those in any of the CONT groups ( Fig. 2A) . The perinephric and epididymal WAT weights in the 0.05% PIP group decreased significantly (Fig. 2B  and C) . These results suggest that body fat accumulation is suppressed by PIP intake.
Suppression of body fat accumulation due to BP intake
Next we investigated the suppressive effect of body fat accumulation due to BP intake. Because HPLC analysis found 62.1 mg of PIP (about 3.0%) in 2,042.8 mg of BP extract, mice were fed an HFS diet to which 1.0% BP was added for 4 weeks. In the 0.03% PIP group, that amount was equal to the amount of PIP included in the 1.0% BP diet of the control group.
Among the CONT, 1.0% BP, and 0.03% PIP diet groups, total food intake and total energy intake over 4 weeks showed similar values (Table 4 ). Although no The values represent the mean AE SEM (n ¼ 6).
significant difference in body weight was found between the CONT and the 0.03% PIP groups, the 1.0% BP group tended to be suppressed in weight (Fig. 3) . The final body weight of the 1.0% BP group was significantly lower than that of the CONT group (Fig. 3) . Thus, although there was no difference in total energy intake, body weight was decreased by a BP diet that contained 0.03% PIP. The organ weights of the heart, spleen, liver, kidney, pancreas, and IBAT were significantly different among the three diet groups (data not shown). The serum component values are shown in Table 5 . Although the serum glucose level showed no significant difference among the diet groups, that of the 1.0% BP group tended to be lower. Compared with the CONT group, total cholesterol and NEFA in the 1.0% BP group decreased significantly. In the 0.03% PIP group, triglyceride increased significantly and totalcholesterol decreased significantly. The weights of the visceral adipose tissues are shown in Fig. 4 . The mesenteric, perinephric, and epididymal WAT weights in the 1.0% BP group decreased significantly as compared with the CONT group (Fig. 4) , and the perinephric and epididymal WAT weights in the 0.03% PIP group decreased significantly as compared with the CONT group (Fig. 4B and C) . The mesenteric WAT weight in the 0.03% PIP group tended to decrease (Fig. 4A) . These results suggest that BP suppresses adiposity as much as or slightly more strongly than PIP.
Next we investigated the amounts of mitochondrial protein and UCP1 in IBAT. UCP1 is a protein that is specifically expressed in brown adipose tissue, and it is an indirect index of sympathetic nerve activity. 10) Among the diet groups, there were no significant differences in the amounts of mitochondrial protein in IBAT (Fig. 5A) . The UCP1 protein contents in IBAT were measured by Western blotting per 2.5 mg of mitochondrial protein. Although the mitochondrial protein content did not change significantly among the diet groups, it was higher in the 1.0% BP group than in the CONT or the 0.03% PIP group (Fig. 5B) . Thus UCP1 protein in IBAT might be increased by BP intake.
Discussion
First we investigated to determine whether PIP suppresses body fat accumulation, as does CAP, a representative TRPV1 agonist. To induce adiposity, mice were fed an HFS diet as a control diet for 4 weeks. The addition of 0.03 and 0.05% of PIP decreased visceral fat weights. In the 0.05% PIP diet group, the final body weight also decreased significantly.
Because PIP is known to be a TRPV1 agonist, [4] [5] [6] the suppression of body fat accumulation may be through TRPV1, as with CAP. The TRPV1 agonist CAP is known to increase energy metabolism by stimulating the sympathetic nervous system. CAP induces adrenaline secretion, which acts on the -adrenergic receptor in the liver and WAT, resulting in decomposition of glycogen in the liver and, triglyceride in the WAT, subsequently enhancing energy metabolism. 7) This hypothesis was supported by a report showing that adrenaline secretion in rats was promoted through intravenous administration of PIP.
11)
Next we investigated the suppressive effect on body fat accumulation of BP intake. Crude BP includes many TRPV1 agonists other than PIP.
6) Hence we thought that BP components, not only PIP but also other TRPV1 agonists, influence the adiposity suppression effect. The HFS diet to which 1.0% BP was added was fed to mice for 4 weeks.
Visceral fat weights were decreased by the 1.0% BP diet. The 1.0% BP diet contains 0.03% PIP. Compared with the control group, final body weight was significantly lowered by the 1.0% BP diet. Total cholesterol Values represent mean AE SEM (n ¼ 6). and NEFA levels in the serum, as well as the weights of visceral fats such as mesenteric, perinephric, and epididymal WAT, were decreased significantly. Conversely, in the 0.03% PIP group, the weights of perinephric and epididymal WAT were decreased significantly, but there was no significant difference in mesenteric WAT. Furthermore, there was no significant difference in final body weight. Although the triglyceride level increased significantly, the total cholesterol and NEFA levels in the serum decreased significantly. In a comparison of the 1.0% BP and 0.03% PIP groups, the 1.0% BP group showed lower values on mesenteric WAT and all serum parameters. Hence it is thought that the difference between the two groups is due to the action of BP components other than PIP.
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To determine whether the suppressive effect on body fat accumulation of BP intake is caused by the activation of sympathetic nerves, the amount of mitochondrial protein and the expression of the UCP1 protein in BAT were measured. Adrenaline secreted by activation of sympathetic nerves acts on the receptor in BAT. Because UCP1 expression increases with the activation of the receptor, UCP1 is an indirect index of sympathetic nerve activity.
10) There were no significant differences in mitochondrial protein among the three diet groups. However, expression of UCP1 protein in the 1.0% BP group tended to increase as compared to the other groups. Thus the adiposity suppression effect by BP intake might be involved in the activation of the sympathetic nerve and the thermogenic protein UCP1. In addition, the existence of BP components other than PIP might increase expression of the UCP1 protein.
Many transient receptor potential cation channels, subfamily A, member 1 (TRPA1) agonists, including PIP, have been found in BP. 6) Activation of TRPA1 reportedly elevates the temperature of brown adipose tissue 12) and induces adrenaline secretion in anesthetized rats. 13) Intake of the TRPA1 agonist also inhibited body fat accumulation. 14) Therefore, TRPA1 activation might play a role in thermogenesis. Thus the adiposity suppression effect due to BP and/or PIP might participate not only in TRPV1 but also in TRPA1.
Deposition of WAT is also prevented by inhibition of fatty acid synthesis of triglyceride decomposition in WAT, by increased energy consumption in the muscles, or by increased fatty acid oxidation and decreased fatty acid synthesis in liver. These are caused through peroxisome-poliferator-activated receptors, AMP-activated protein kinase, or other factors. The effects of pepper components on such factors should be clarified. In this study, we clarified the suppressive effects on body fat accumulation of PIP and of BP intake. However, since the suppressive effects on BP was greater than that of PIP alone, fat accumulation can be influenced not only by PIP but also by other BP components. 
